Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

3 Top Reasons Bitcoin Price Can Reach $47,000 By December, While Traders Place $20,000 in Bitcoin ETF Token ICO

Published

on

3-top-reasons-bitcoin-price-can-reach-$47,000-by-december,-while-traders-place-$20,000-in-bitcoin-etf-token-ico

NEW YORK, Nov. 6, 2023 /PRNewswire/ — The Bitcoin price can hit $47,000 in December for three reasons, making the Bitcoin ETF token a must-buy at ICO for those who want exposure to the Bitcoin ETF theme.

Bitcoin halving, the launch of a spot Bitcoin ETF, and the Bitcoin digital gold thesis are the three factors combining to send the top cryptocurrency’s price to $47,000 by December, and possibly into the $60,000s early next year.

An expected bull run that accompanies the Bitcoin halving cycles has probably already begun – providing the first major reason for the doubling in the price of Bitcoin since its near-term lows printed in November last year.

The logarithmic price chart below showing the previous Bitcoin halving epochs illustrates the powerful price-positive driver that accompanies the reduction of the bitcoin block reward. In April 2024 the reward halves from 6.25 to 3.125 Bitcoin per block mined.

Best way to position your portfolio for stellar returns for when a spot Bitcoin ETF is approved

However, a second reason for bullish sentiment returning to the market is undoubtedly the narrowing odds that the US Securities and Exchange Commission (SEC) will approve a spot Bitcoin ETF, as soon as January next year.

In anticipation, traders have already started diverting their cash into Bitcoin derivative coins such as the Bitcoin ETF Token ($BTCETF) in order to be ready for the approval of a spot Bitcoin ETF.

Traders are incentivized to buy the $BTCETF token in the presale through the ecosystem’s staking feature. At the time of writing more than 3 million $BTCETF tokens have been staked, earning an astronomical annual percentage yield (APY) of 10,000-plus. The yield will taper lower as more funds are deposited into the staking smart contract.

Burn mechanism tied to real-world events such as trading volume and spot Bitcoin ETF approval and launch dates

Bitcoin ETF Token launches with a 5% burn mechanism on all transactions. Up to 25% of the total token supply is eligible to be burned.

Ingeniously, the burn mechanism is tied to real-world events related to spot Bitcoin ETF news flow, where milestones such as approval and launch dates and the level of assets under management (AUM), trigger burn events.

For instance, when the trading volume of $BTCETF reaches $100 million the transaction tax reduces from 5% to 4%. There are other clever milestones, such as when the first spot Bitcoin ETF is approved the sales tax reduces from 4% to 3%.

If you are looking to ride the enthusiasm surrounding the hottest investment in crypto right now, Bitcoin ETF Token is the best way to get your portfolio positioned for when the SEC approves the first spot Bitcoin ETF.

Bitcoin ETF Token has a total supply of 2.1 billion (2,100,000,000). The project’s website has a helpful newsfeed to keep you up to date with all the news related to Bitcoin ETFs and the Bitcoin price.

The $BTCETF token is the best way to play the spot Bitcoin ETF theme. The token is in presale now and only costs $0.005. There is a hard cap total of just under $5 million, with the presale divided into 10 price stages, so investors need to buy today to lock in the lowest possible prices.

Bitcoin is digital gold – and Bitcoin ETF Token is a cheap way of getting in on the action

Our third reason why Bitcoin can hit $40,000 in November is the persistent attractiveness of Bitcoin as a store of value – the digital gold narrative is coming to the fore once more. Again, purchasing Bitcoin ETF Token is a way of gaining exposure to this third leg of the bull case for Bitcoin.

There’s nothing like war and economic uncertainty to stir the pot for gold bullion and Bitcoin is arguably a more portable and divisible version of that asset, with similar investable properties, but without the custodial costs required to store it in a vault.

ARK Invest founder Cathie Wood outlined the digital gold case for Bitcoin in a recent Bloomberg interview, tweeted below:

https://x.com/Washigorira/status/1720402205885317499

With Bitcoin ETF Token there is no expense ratio fee deductions you see with ETFs

Also worth mentioning is the fact that buying the Bitcoin ETF Token is a cheaper way to gain exposure to the Bitcoin value proposition via an actual spot Bitcoin ETF.

ETFs come with management fees. Although the total expense ratio (the percentage of returns deducted for fees) is usually less than 1%, making ETFs cheaper than mutual funds, the expenses can still add up to a lot of money, especially for bigger pots.

When you buy $BTCETF tokens you pay a one-off amount to cover the gas fees on Ethereum, as opposed to having to fork out an ongoing annual percentage charge.

There is also no pesky tracking error (when the underlying asset and the ETF price diverge slightly) to worry about, as there is with exchange-traded funds.

Dollar losing its luster, Bitcoin gaining a shine and it’s programmable too

Those are the three major reasons, but there are other positives associated with the macroeconomic backdrop and Bitcoin protocol fundamentals.

On that, the waning power of the dollar and sticky inflation make a disinflationary asset like Bitcoin a great portfolio diversifier, even if that wasn’t really apparent when inflation first returned as a top concern for policymakers.

At the protocol level developments around NFT ordinals demonstrated the flexibility of Bitcoin as a programmable form of money that is practically, and theoretically, able to adapt and evolve.

Despite the much-talked-about governance drawbacks that have previously slowed progress, the hype around ‘inscriptions’, which allowed block space to be used for unintended and novel purposes such as storing NFTs, showed what is possible.

Even if you are doubtful of the value proposition of NFT ordinals, their existence proves the point about the revolutionary extensibility of Bitcoin.

Transactions surged on the Bitcoin blockchain when ordinals innovation began, leading to criticism in some quarters that they were clogging up the chain and pressuring transaction fees higher. Nevertheless, it showed the innovative possibilities of the Bitcoin protocol in contrast to the sterility of non-programmable fiat money.

How spot Bitcoin ETF approval can propel the Bitcoin price to $60,000 going into 2024

A spot Bitcoin ETF approval could send the Bitcoin Price on a journey to $47,000 – the Bitcoin ETF Token is a cheap and clever way to play this investment theme

Having reestablished itself around the $35,000 level, traders are looking at upside Bitcoin price targets between $47,000 and $60,000 going into 2024.

If the price stays within its current ascending channel then it could hit $47,000 as early as December.

But the Bitcoin price could blast off in January because it is on the 10th of that month that the deadline for an SEC decision on whether to approve the ARK 21 Shares Bitcoin ETF comes round.

An approval could see the price break out of the identified channel and arc higher on a trajectory to $47,000, where it will likely meet some resistance that formed at that level in April 2022.

Assuming Bloomberg Intelligence analysts who have nailed their mast to a 90% probability of a spot Bitcoin ETF being approved are correct, then a steady flow of other approvals will follow, including the big one – BlackRock’s iShares Bitcoin Trust ETF. BlackRock is the largest asset manager in the world.

Fuelling the speculation, and the contention that an approval is inevitable, was the inclusion of the iShares fund in the eligibility file of the DTCC (Depository Trust & Clearing Corporation) clearing house, which handles post-trade settlement for US financial markets.

Although the iShares ETF’s inclusion in the file does not mean an approval is confirmed, it is a step that is indicative of such an outcome. No previous spot Bitcoin ETF applications have been included in the DTCC list.

The news propelled the Bitcoin price on a two-day rally to an 18-month high of $35,180, which is where the price is still currently trading.

After settling at $47,000 there is an open road ahead for the price to climb back into the $60,000s and to challenge the all-time high at $68k.

Spot Bitcion ETF and the $BTCETF token can open the floodgates to new money

Not surprisingly then, of all the three major reasons behind the push to $40,000, market participants will be most focused on the prospects for a spot Bitcoin ETF and how it and other Bitcoin derivatives such as Bitcoin ETF Token can play a part in opening up the floodgates to new money.

Exchange-traded funds will provide both retail and institutional investors with safe and hassle-free ways of gaining exposure to Bitcoin.

There will be no need to risk funds by investing in a latter day FTX, for example, which could open up investor money to fraud and losses.

Spot Bitcoin ETF issuers include the great and the good of the investment management world, from BlackRock to Fidelity and relative upstarts such as ARK Invest.

Having highly regulated and well-supervised companies such as the aforementioned entering the crypto space may be a threat to some ‘crypto native’ incumbents such as centralized exchanges. But for retail investors it means more security and choice, and for institutional clients it provides a regulated on-ramp.

The opening today of the Bitcoin ETF Token presale provides investors with perhaps the smartest way to leverage the investment theme around the spot Bitcoin ETF. It could be the best thing that happens to your crypto investment portfolio.

Photo – https://mma.prnewswire.com/media/2267739/bitcoin_etf_token_website.jpg
Photo – https://mma.prnewswire.com/media/2267740/BTCUSD_price_targets.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/3-top-reasons-bitcoin-price-can-reach-47-000-by-december-while-traders-place-20-000-in-bitcoin-etf-token-ico-301979085.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading
Advertisement
Advertisement

Latest news

Trending